U.S. Markets closed

Amneal Pharmaceuticals, Inc. (AMRX)

NYSE - NYSE Delayed Price. Currency in USD
2.2000+0.1100 (+5.26%)
At close: 04:00PM EST
2.2000 0.00 (0.00%)
After hours: 05:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0900
Bid2.1200 x 3000
Ask2.1800 x 4000
Day's Range2.1050 - 2.2000
52 Week Range1.9500 - 4.9800
Avg. Volume1,213,727
Market Cap328.616M
Beta (5Y Monthly)1.26
PE Ratio (TTM)3.61
EPS (TTM)0.6100
Earnings DateFeb 28, 2023 - Mar 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
  • Business Wire

    Amneal to Report Fourth Quarter and Full Year 2022 Results on March 2, 2023

    BRIDGEWATER, N.J., January 31, 2023--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its fourth quarter and full year 2022 financial results on Thursday March 2, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on March 2, 2023.

  • Investor's Business Daily

    Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years

    Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.

  • Bloomberg

    US Releases Stockpiled Tamiflu Supplies Amid Cold, Flu Treatment Shortages

    (Bloomberg) -- US health officials have released supplies of the flu drug Tamiflu from a national stockpile as shortages of cold and respiratory medications persist nationwide.Most Read from BloombergElon Musk Fan With 2,900% Gain Sees $1.5 Million Wiped AwayUS Inflation Cools Again, Putting Fed on Track to DownshiftT-Mobile Considers Buying Ryan Reynolds’s Mint MobileThe Document That Separates Biden and TrumpGoogle, Nvidia Express Concerns to FTC About Microsoft’s Activision DealMore than 52,0